rs71647871
From SNPedia
Orientation | minus |
Stabilized | minus |
Geno | Mag | Summary |
---|---|---|
(G;G) | 0 | common in complete genomics |
Make rs71647871(A;A) |
Make rs71647871(A;G) |
Reference | GRCh38 38.1/142 |
Chromosome | 16 |
Position | 55823658 |
Gene | CES1 |
is a | snp |
is | mentioned by |
dbSNP | rs71647871 |
dbSNP (classic) | rs71647871 |
ClinGen | rs71647871 |
ebi | rs71647871 |
HLI | rs71647871 |
Exac | rs71647871 |
Gnomad | rs71647871 |
Varsome | rs71647871 |
LitVar | rs71647871 |
Map | rs71647871 |
PheGenI | rs71647871 |
Biobank | rs71647871 |
1000 genomes | rs71647871 |
hgdp | rs71647871 |
ensembl | rs71647871 |
geneview | rs71647871 |
scholar | rs71647871 |
rs71647871 | |
pharmgkb | rs71647871 |
gwascentral | rs71647871 |
openSNP | rs71647871 |
23andMe | rs71647871 |
SNPshot | rs71647871 |
SNPdbe | rs71647871 |
MSV3d | rs71647871 |
GWAS Ctlg | rs71647871 |
GMAF | 0.01148 |
Max Magnitude | 0 |
[PMID 25704243] Carboxylesterase 1 c.428G>A single nucleotide variation increases the antiplatelet effects of clopidogrel by reducing its hydrolysis in humans
ClinVar | |
---|---|
Risk | rs71647871(A;A) |
Alt | rs71647871(A;A) |
Reference | Rs71647871(G;G) |
Significance | Drug-response |
Disease | clopidogrel response - Efficacy |
Variation | info |
Gene | CES1 |
CLNDBN | clopidogrel response - Efficacy |
Reversed | 1 |
HGVS | NC_000016.9:g.55857570C>T |
CLNSRC | PharmGKB Clinical Annotation |
CLNACC | RCV000211163.1, |